Kaldvik AS remains in severe financial and biological distress. Recurring biological disasters—most recently severe jellyfish attacks causing over 18% cumulative mortality on the 2025 generation—have triggered loan covenant breaches and forced the company into temporary lender waiver agreements. Coupled with persistent negative operational EBIT and high net interest-bearing debt, the stock carries acute insolvency and extreme equity dilution risks, making it unsuitable for retail investors.
Price Movement
Price and Stoxie target over time
Kaldvik AS remains in severe financial and biological distress. Recurring biological disasters—most recently severe jellyfish attacks causing over 18% cumulative mortality on the 2025 generation—have triggered loan covenant breaches and forced the company into temporary lender waiver agreements. Coupled with persistent negative operational EBIT and high net interest-bearing debt, the stock carries acute insolvency and extreme equity dilution risks, making it unsuitable for retail investors.
Sentiment
Sentiment from official company announcements and reports.
The voice of retail investors and social media chatter.
5 threads
Sentiment from news across the company's specific industry.
0 articles
Sentiment from news across the broader market sector.
0 articles
Financial Hub
Market cap
$656.25M
P/E ratio
N/A
Div. yield
0.00%
Quarterly EPS Surprise
Comparing actual earnings to analysts' estimates.